Please use this identifier to cite or link to this item:
Title: Remifentanil in labour: retrospective audit of a single regional centre’s outcomes.
Author: Pillay, Monisha
Shaw, Michael
Vincent, C.
Frawley, Natasha
Issue Date: 2019
Conference Name: PSANZ2019 – Perinatal Society of Australia and New Zealand Annual Scientific Meeting
Conference Date: March 17-20
Conference Place: Gold Coast
Abstract: Background: Remifentanil is a potent short acting opioid which is rapidly metabolised by mother and fetus. Despite positive data published in a meta‐analysis, remifentanil is not used widely in Victoria for labour analgesia. Ballarat Health Services has approximately 1,400 births per annum with Remifentanil being offered as patient controlled analgesia to women in labour. The aim of this retrospective cohort study was to determine the efficacy, patient satisfaction and maternal and neonatal adverse effects profile of remifentanil. Methods: A retrospective cohort study was conducted over a period of 6 months, from January to June 2018 of all births at a single regional centre. Subjects were identified via routinely collected birth data. Dose of Remifentanil was 20mcg/mL. Four parameters had data collected including maternal demographics, labour, analgesia and neonatal outcomes. Results: Of 641 births, 45 patients used remifentanil. Patients were 19‐ 40 years old with BMIs of 20‐38 and generally over 37 weeks gestation. 2 patients required Remifentanil for management of a FDIU. 17 patients presented in spontaneous labour with 18 having inductions mainly due to high BMI and GDM. 67% of patient used Nitrous prior to Remifentanil with 18% of patients requiring an epidural. 7% required an instrumental delivery subsequent to remifentanyl. 100% of neonates had a 5‐minute APGAR >6 with 7% requiring a SCN admission and 2% of neonates requiring resuscitation at birth. Conclusions: This audit indicates that the use of Remifentanil in labour was associated with a high subsequent vaginal delivery rate and no significant adverse neonatal outcomes as a direct result.
Internal ID Number: 01482
Health Subject: LABOUR
Type: Conference
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.